Epigenome-wide association study identifies a specific panel of DNA methylation signatures for antenatal and postpartum depressive symptoms
Journal of Affective Disorders · 2025
DOI: 10.1016/j.jad.2025.04.083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Chinnasamy Thirumoorthy und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurochemistry, National Institute of Mental Health & Neuro Sciences (NIMHANS), Bengaluru, India. Hauptthemen laut MEDLINE: DNA Methylation, Depression, Postpartum, Pregnancy Complications, Epigenome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Department of Health Research, India, Wellcome Trust DBT India Alliance.
Themen: Depression
Abstract (Originalsprache)
Depression during pregnancy and postpartum poses significant risks to both maternal and child well-being. The underlying biological mechanisms are unclear, but epigenetic variation could be exploited as a plausible candidate for early detection. We investigated whether DNA methylation signatures are associated with antenatal depressive symptoms (ADS) and whether early alterations in methylation patterns could be used to predict postpartum depressive symptoms (PDS). 201 pregnant women in early pregnancy, without a prior history of depressive disorders, from the STratification of Risk of Diabetes in Early Pregnancy study (STRiDE) were recruited. Using the Patient Health Questionnaire-9 (PHQ-9), 92 women were identified with ADS, while 109 served as controls. Edinburgh Postnatal Depression Scale (EPDS) was used to assess PDS during 6-12 weeks after delivery. The dataset was split into 80 % for training and testing and 20 % for validation, to discern potential CpGs for ADS using a support vector machine classifier. Analysis revealed 591 CpGs significantly associated with ADS, from which a panel of 7 CpGs was identified to discriminate between ADS and controls with high sensitivity and specificity (AUC: 0.85 in test, 0.73 in validation). Pathway analysis highlighted involvement in inositol phosphate metabolism, notch, and calcium signaling. The same 7 CpGs predicted PDS with an AUC of 0.76 (95 % CI: 0.66-0.87). Integration of CpG data with patient-reported information significantly enhanced PDS prediction. Our study identified DNA methylation signatures that could potentially differentiate ADS from controls and predict PDS. This suggests potential for developing a CpG panel for diagnostic and preventive strategies for perinatal depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurochemistry, National Institute of Mental Health & Neuro Sciences (NIMHANS), Bengaluru, India.
- Biostatistics, National Institute of Mental Health & Neuro Sciences (NIMHANS), Bengaluru, India.
- Department of Diabetology, Madras Diabetes Research Foundation (MDRF), Chennai, India.
- Department of Molecular Genetics, Madras Diabetes Research Foundation (MDRF), Affiliated to University of Madras, Chennai, India.
- Neurophysiology, National Institute of Mental Health & Neuro Sciences (NIMHANS), Bengaluru, India.
- Institute of Epidemiology, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | HZM, Germany.
Förderung
- Department of Health Research, India
- Wellcome Trust DBT India Alliance
Zitieren
APA
Thirumoorthy, C., Sharma, K. K., Deepa, M., Yogaprabhu, S., Sneha, J., Rekha, R. P., Venkatesan, U., Hemavathy, S., Nikhil, J., Srikumar, B. N., Binukumar, B., Radha, V., Sharma, S., Grallert, H., Ball, G., Ram, U., Anjana, R. M., Balasubramanyam, M., Tandon, N., …, & Gokulakrishnan, K. (2025). Epigenome-wide association study identifies a specific panel of DNA methylation signatures for antenatal and postpartum depressive symptoms. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.04.083
Vancouver
Thirumoorthy C, Sharma KK, Deepa M, Yogaprabhu S, Sneha J, Rekha RP, et al. Epigenome-wide association study identifies a specific panel of DNA methylation signatures for antenatal and postpartum depressive symptoms. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2025.04.083
BibTeX
@article{Thirumoorthy2025,
author = {Thirumoorthy, Chinnasamy and Sharma, Kuldeep Kumar and Deepa, Mohan and Yogaprabhu, Saravanan and Sneha, Janaki and Rekha, Ravikumar Pavithra and Venkatesan, Ulagamadesan and Hemavathy, Saite and Nikhil, Joyappa and Srikumar, Bettadapura N and Binukumar, Bhaskarapillai and Radha, Venkatesan and Sharma, Sapna and Grallert, Harald and Ball, Graham and Ram, Uma and Anjana, Ranjit Mohan and Balasubramanyam, Muthuswamy and Tandon, Nikhil and Mohan, Viswanathan and Saravanan, Ponnusamy and Gokulakrishnan, Kuppan},
title = {Epigenome-wide association study identifies a specific panel of DNA methylation signatures for antenatal and postpartum depressive symptoms},
journal = {Journal of Affective Disorders},
year = {2025},
doi = {10.1016/j.jad.2025.04.083}
}
EUVIMED